Glaukos stock slips after insider selling (GKOS:NYSE)
· seekingalpha.com
Glaukos Corporation (GKOS) stock drops after an insider sale overshadowed positives from a late-stage trial for the company's Epioxa eye therapy. Read more here.
Despite announcing positive data from a late-stage trial for its Epioxa eye therapy, Glaukos Corporation (GKOS) lost more than 13% on Thursday amid an insider s...